Sandy Adjemian
Affiliations: | University Paris 11 |
Area:
Immunogenic chemotherapies, Cancer, ATP, Autophagy, Antigen presenting cellsGoogle:
"Sandy Adjemian"Parents
Sign in to add mentor| Guido Kroemer | grad student | 2012 | University Paris 11 | |
| (Facteurs essentiels pour le succès des chimiothérapies immunogènes) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Oltean T, Lippens L, Lemeire K, et al. (2022) Association of Cell Death Markers With Tumor Immune Cell Infiltrates After Chemo-Radiation in Cervical Cancer. Frontiers in Oncology. 12: 892813 |
| Wiernicki B, Maschalidi S, Pinney J, et al. (2022) Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nature Communications. 13: 3676 |
| Adjemian S, Oltean T, Martens S, et al. (2020) Ionizing radiation results in a mixture of cellular outcomes including mitotic catastrophe, senescence, methuosis, and iron-dependent cell death. Cell Death & Disease. 11: 1003 |
| Le Naour J, Liu P, Zhao L, et al. (2020) A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency. Cancer Discovery |
| Galluzzi L, Vitale I, Warren S, et al. (2020) Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. Journal For Immunotherapy of Cancer. 8 |
| Aaes TL, Verschuere H, Kaczmarek A, et al. (2020) Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection. Journal of Immunology (Baltimore, Md. : 1950) |
| Amarante-Mendes GP, Adjemian S, Branco LM, et al. (2018) Pattern Recognition Receptors and the Host Cell Death Molecular Machinery. Frontiers in Immunology. 9: 2379 |
| Catani JP, Adjemian S, Riechelmann RP, et al. (2017) Near future of tumor immunology: Anticipating resistance mechanisms to immunotherapies, a big challenge for clinical trials. Human Vaccines & Immunotherapeutics. 0 |
| Catani JP, Medrano RF, Hunger A, et al. (2016) Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma. Translational Oncology. 9: 565-574 |
| Vacchelli E, Ma Y, Baracco EE, et al. (2015) Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. Science (New York, N.Y.) |